← All diseases
Lungs and airways
Pulmonary fibrosis (IPF)
Would you like to receive a message when there is new research on Idiopathic Pulmonary Fibrosis (IPF)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was researched — and you'll receive a notification as soon as there is new research on Pulmonary Fibrosis (IPF). View what Premium costs.
Publications and studies (1939)
- Synergistic inhibition of the PI3K-AKT-mTOR signaling pathway in idiopathic pulmonary fibrosis by Sanleng-Ezhu: a multi-omics and experimental study. (2026/06/27) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Genetic Landscape of Fibrotic Interstitial Lung Diseases: Clinical Implications and Diagnostic Challenges in Familial Pulmonary Fibrosis. (2026/06/25) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Comparative efficacy of different types of structured exercise interventions for idiopathic pulmonary fibrosis: a systematic review and meta-analysis. (2026/06/12) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Olive Oil and the Impact of Gastrointestinal Adverse Events During Pirfenidone Treatment in Idiopathic Pulmonary Fibrosis: A Post-hoc Analysis of the MADIET Trial. (2026/06/08) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Geranylgeranylacetone Alleviates Pulmonary Fibrosis in Mice by Activation of Nrf2 /HO-1/NQO1 Pathway. (2026/06/01) ♡
- Outcomes After Acute Respiratory Failure in Patients With Interstitial Lung Disease. (2026/06/01) ♡
- [Effect of Maxing Kugan Decoction on intestinal flora in bleomycin-induced idiopathic pulmonary fibrosis rats]. (2026/06/01) ♡
- [Investigating on mechanism of Yangyin Yifei Tongluo Pills in improving idiopathic pulmonary fibrosis based on bioinformatics and machine learning combined with UHPLC-Q Exactive Orbitrap-HRMS]. (2026/06/01) ♡
- Relationship of prognostic nutritional index with clinical outcomes and survival in idiopathic pulmonary fibrosis. (2026/05/29) ♡
- Life's Essential 8 and the incidence and progression trajectory of chronic lung diseases: A multistate analysis of a prospective cohort study. (2026/05/29) ♡
- Study on the anti-pulmonary fibrosis mechanism of Renshen Pingfei formula by inhibiting M2 macrophage polarization and regulating TGF - β/SMAD signaling pathway. (2026/05/23) ♡
- Activation of the impaired NAMPT/SIRT7/SOD2 axis restores alveolar progenitor cell renewal in idiopathic pulmonary fibrosis. (2026/05/07) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. When history can mislead a physician: a challenging case report of idiopathic pulmonary hemosiderosis-A case report and review of the literature. (2026/05/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Progressive pulmonary fibrosis. (2026/05/01) ♡
- Prognostic Value of a Cardiopulmonary Exercise Testing-Derived Summed Score in Idiopathic Pulmonary Fibrosis and Connective Tissue Disease-Associated Interstitial Lung Disease: A Prospective Cohort Study. (2026/05/01) ♡
- Serum concentration of Surfactant protein D at diagnosis is associated with malnutrition in patients with idiopathic pulmonary fibrosis. (2026/05/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. 2,5-Dimethylcelecoxib inhibits lung fibrosis in a mouse model of bleomycin-induced pulmonary fibrosis. (2026/05/01) ♡
- Dietary intake and BCAA metabolism regulate pulmonary fibrosis through KDM4A-mediated epigenetic remodeling in male mice. (2026/04/27) ♡
- Kangxianhuanji formula and its component rutin ameliorate acute exacerbation of idiopathic pulmonary fibrosis by targeting GLUT1 to suppress HIF-1α-mediated glycolysis. (2026/04/24) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Holistic Management of Pulmonary Fibrosis: A Comprehensive Review. (2026/04/24) ♡
- Prognostic Impact of Serum Transthyretin and Sarcopenia on 3-Year Mortality and Respiratory-Related Hospitalizations in Idiopathic Pulmonary Fibrosis: A Prospective Cohort Study. (2026/04/08) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Organising pneumonia in ulcerative colitis with primary sclerosing cholangitis: drug-related toxicity or extraintestinal manifestation? (2026/04/07) ♡
- Epstein-Barr virus-related antibody traits and idiopathic pulmonary fibrosis: a bidirectional Mendelian randomization study. (2026/04/03) ♡
- Serum Krebs von den Lungen-6 Level as a Reflecting Biomarker in Patients with Interstitial Lung Abnormalities. (2026/04/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Advanced lung segmentation on chest HRCT: comprehensive pipeline for quantification of airways, vessels, and injury patterns. (2026/04/01) ♡
- Non-pharmacological Management of Fibrosing Interstitial Lung Diseases. (2026/04/01) ♡
- Geriatric nutritional risk index in antifibrotic therapy can predict tolerability and mortality risk. (2026/04/01) ♡
- CDKN2A/p16 Exon 2 Hypermethylation in Lung Squamous Cell Carcinoma Associated with Interstitial and Emphysematous Lung Diseases: A Comparative Analysis of Tumor, Adjacent and Distant Lung Tissues. (2026/03/27) ♡
- Combined HDL-BMI Phenotyping Provides Incremental Prognostic Value in Idiopathic Pulmonary Fibrosis. (2026/03/26) ♡
- Development and internal validation of a machine learning-based model for predicting 2-year mortality in interstitial lung disease. (2026/03/19) ♡
- The COCOS-IPF core outcome set for idiopathic pulmonary fibrosis/progressive pulmonary fibrosis care: a mixed-method multi-perspective approach. (2026/03/16) ♡
- Inhaled biomimetic nanoparticles enhance pulmonary delivery of tetrandrine and pirfenidone for the treatment of idiopathic pulmonary fibrosis. (2026/03/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Artificial intelligence in the development of Rentosertib: A novel TNIK inhibitor for idiopathic pulmonary fibrosis - A letter to editor. (2026/03/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. "One size does not fit all": Personalized approach to define appropriate level of palliative care in newly diagnosed idiopathic pulmonary fibrosis patients. (2026/03/01) ♡
- Subset binding enables detection of multimodal patient subgroup patterns and drug target discovery in idiopathic pulmonary fibrosis. (2026/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Natural senotherapeutics in respiratory health: Addressing cellular senescence, inflammaging, and immunosenescence in the aging lung. (2026/02/28) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Monoallelic PARN mutation presenting as pancytopenia, hepatic fibrosis and idiopathic pulmonary fibrosis. (2026/02/25) ♡
- Transcriptomic signatures of IPF in ALI-cultured airway cells and their therapeutic implications. (2026/02/18) ♡
- Discovery of kaempferol derivatives as novel PDE4 inhibitors for treatment of idiopathic pulmonary fibrosis. (2026/02/15) ♡
- Yizong Tongluo formula attenuates idiopathic pulmonary fibrosis and inflammatory injury by inhibiting HIF-1α/LSH/SCD1-mediated ferroptosis. (2026/02/11) ♡
- Inhalable nanosystem promote in situ packaging of IL-11 antisense oligonucleotides into macrophage-derived vesicles for idiopathic pulmonary fibrosis. (2026/02/10) ♡
- Melittin-loaded solid lipid nanoparticles inhibit pulmonary fibrosis via the NOVA2-TGF-β/Smads signaling pathway. (2026/02/01) ♡
- Decoding tamoxifen on idiopathic pulmonary fibrosis: integrating network toxicology and multi-omics. (2026/02/01) ♡
- Associations between dietary patterns and the incidence of idiopathic pulmonary fibrosis: A cohort study. (2026/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Astragaloside IV: A multipotent phytochemical for treating fibrotic diseases (Review). (2026/02/01) ♡
- Yifei Decoction Regulates the NGF/TRKA/PI3K/AKT Signaling Axis to Inhibit the Epithelial-Mesenchymal Transformation and Proliferation of Pulmonary Epithelial Cells in Bleomycin-Induced Pulmonary Fibrogenesis. (2026/01/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Iron homeostasis and macrophage polarization in pulmonary fibrosis: mechanisms and therapeutic perspectives. (2026/01/15) ♡
- A seven-gene panel with diagnostic and prognostic value for idiopathic pulmonary fibrosis and candidate herbal drugs identified based on these genes. (2026/01/15) ♡
- Rubiadin-1-methyl ether alleviates bleomycin induced pulmonary fibrosis. (2026/01/08) ♡
- The role of age-related genes in idiopathic pulmonary fibrosis and molecular docking analysis of their drug targets. (2026/01/05) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.